| Literature DB >> 30060536 |
Markus Witzler1, Abla Alzagameem2,3, Michel Bergs4,5, Basma El Khaldi-Hansen6, Stephanie E Klein7, Dorothee Hielscher8, Birgit Kamm9,10, Judith Kreyenschmidt11, Edda Tobiasch12, Margit Schulze13.
Abstract
Renewable resources are gaining increasing interest as a source for environmentally benign biomaterials, such as drug encapsulation/release compounds, and scaffolds for tissue engineering in regenerative medicine. Being the second largest naturally abundant polymer, the interest in lignin valorization for biomedical utilization is rapidly growing. Depending on its resource and isolation procedure, lignin shows specific antioxidant and antimicrobial activity. Today, efforts in research and industry are directed toward lignin utilization as a renewable macromolecular building block for the preparation of polymeric drug encapsulation and scaffold materials. Within the last five years, remarkable progress has been made in isolation, functionalization and modification of lignin and lignin-derived compounds. However, the literature so far mainly focuses lignin-derived fuels, lubricants and resins. The purpose of this review is to summarize the current state of the art and to highlight the most important results in the field of lignin-based materials for potential use in biomedicine (reported in 2014⁻2018). Special focus is placed on lignin-derived nanomaterials for drug encapsulation and release as well as lignin hybrid materials used as scaffolds for guided bone regeneration in stem cell-based therapies.Entities:
Keywords: biomaterial; bone regeneration; drug release; hydrogel; lignin; multivariate data processing; osteogenesis; scaffolds; stem cells; tissue engineering
Mesh:
Substances:
Year: 2018 PMID: 30060536 PMCID: PMC6222784 DOI: 10.3390/molecules23081885
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Lignocellulosic feedstock biorefinery [4]. Copyright 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Number of scientific publications on “lignins” refined by “lignin in drug release” and “lignin scaffolds” according to Web of Science, searched on 20 June 2018.
| Publication Years | “Lignin” | “Lignin and Drug Release” | “Lignin and Scaffolds” |
|---|---|---|---|
| 2014 | 2856 | 3 | 23 |
| 2015 | 3269 | 5 | 25 |
| 2016 | 3672 | 10 | 35 |
| 2017 | 3893 | 12 | 39 |
| 2018 | 1783 | 8 | 13 |
Number of patents specifying “lignin”, refined by “lignin in drug release” and “lignin scaffolds”, respectively, according to World Intellectual Property Organization (WIPO), searched on 20 June 2018.
| Filing Year | “Lignin” | “Lignin and Drug Release” | “Lignin and Scaffolds” |
|---|---|---|---|
| 2014 | 5877 | 474 | 683 |
| 2015 | 5766 | 440 | 601 |
| 2016 | 5912 | 449 | 601 |
| 2017 | 5264 | 412 | 488 |
| 2018 | 1691 | 153 | 183 |
Figure 2Products of a lignocellulosic feedstock biorefinery [7]. Copyright 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figure 3Structure of the three monolignol precursors and their corresponding fragments in the macromolecules.
Figure 4Lignin linkages: ether bonds, carbon-carbon bonds, and further linkages.
Figure 5(a) HSQC NMR spectrum, aromatic region (dC/dH 100–150/6.0–8.0) of lignin samples obtained via Organosolv process from Miscanthus X giganteus. Comparison of leaf lignin (blue) and stem lignin (red) and (b) corresponding assigned lignin fragments. Copyright Springer 2018.
Figure 6Examples of controlled release platforms. (A) Matrix tortuosity-controlled diffusion; (B) Membrane-controlled diffusion; (C) Hydrogels [62]. Copyright 2018 John Wiley and Sons.
Figure 7An environmentally benign antimicrobial nanoparticle based on a silver-infused lignin core. (a) General mechanism for the antimicrobial action of common AgNPs via the release of Ag+ ions, which continues post-utilization; (b) Mechanism of antimicrobial action of Ag+ ion-infused EbNPs with a cationic polyelectrolyte coating that facilitates electrostatic attraction between the EbNPs and negatively charged cell walls. In contrast to AgNPs, EbNPs are depleted of Ag+ ions during their application, minimizing their post-utilization activity; (c) TEM micrograph of as-synthesized EbNPs in the size range of 40–70 nm; (d) Confocal microscopy image of EbNPs with polyelectrolyte coating adhering to the cell membrane of E. coli. [63]. Copyright 2018 Springer Nature.
Lignin-derived systems for biomedical applications: drug release and antibacterial use.
| Application | Matrix Type | Encapsulation Method and Active Ingredient | Results | References |
|---|---|---|---|---|
| drug release | lignin nanoparticles from Indulin AT | nanoparticle flash precipitation with subsequent silver ion infusion and polyelectrolyte coating | >95% release of silver ions in 24 h and antibacterial effect against | Richter et al. 2015 [ |
| drug release | lignin nanoparticles from LignoBoostTM softwood Kraft lignin | incorporation of poorly water-soluble Sorafenib® and Benzazulene® during particle formation via polarity change | poorly water-soluble drugs are released upon degradation of the particles; the water-soluble drug could not be incorporated into the nanoparticle; low cytotoxic effects on cancer cell lines: MDA-MB-231, MCF-7, PC3-MM2, Caco-2 and non-tumor cells: KG1 and EA.hy926 endothelial cells | Figueiredo et al. 2017 [ |
| drug release | lignin nanospheres from enzymatic hydrolysis lignin | no drug loading | lignin nanoparticles with tunable size can be produced via self-assembly | Xiong et al. 2017 [ |
| drug release | lignin nanoparticles from alkaline lignin | incorporation of Resveratrol® during particle formation via polarity change | about 80% drug released into phosphate buffer saline (PBS) after 4 days | Dai et al. 2017 [ |
| drug release | polyelectrolyte microparticles of quaternary ammonium lignin-sodium dodecyl benzenesulfonate (lignin from pine alkali lignin) | loading of hydrophobic Avermectine during particle precipitation | release of ~80% Avermectine into methanol:water (1:1) after 72 h; good UV protection of the drug (85% preserved after 96 h UV irradiation 30 W, 310 nm) | Li et al. 2018 [ |
| drug release | lignin droplets in W/O Pickering emulsion coated with polyurea | loading of hydrophobic Avermectine in emulsion before droplet coating reaction | release of 85% of Avermectine into 4:1 ethanol:water after 72 h; lignin-polyurea coatings were more porous than pure polyuria layers, which showed a more sustained release; UV protection of lignin coatings was good (>75% preserved after 120 h irradiation 30 W, 310 nm) | Pang et al. 2018 [ |
| drug release | montmorillonite/lignin-acrylamide-isopropyl acrylamide copolymer | adsorption of methylene blue from aqueous solution | effective removal of dyes from aqueous solutions over multiple sorption/desorption cycles | Wang et al. 2017 [ |
| drug release | crosslinked cellulose-lignin hydrogels (steam expansion lignin, aspen wood) | swelling of gel in polyphenol solution | a higher lignin content leads to a faster drug release, up to 30% in 10 h | Ciolacu et al. 2012 [ |
| antibacterial effect | lignin nanoparticles in polyethylene films (Björkman lignin from beech wood flour) | none | lignin particles exhibit antibacterial effect against | Gregorova et al. 2011 [ |
Figure 8The differentiation potential of mesenchymal stem cells [13]. Copyright 2018 Springer eBook.
Figure 9Stem cell and their natural microenvironment. Factors influencing the stem cell niche can be roughly categorized in three groups: physical and mechanical factors such as shear forces, elasticity and topography, cellular issues such as immune and nerve cells, nearby blood vessels and neighboring stem cells and soluble factors such as oxygen, glucose, hormones, growth factors or signaling molecules [13]. Copyright 2018 Springer Verlag.
Figure 10Fabrication methods used for the development of nanostructured scaffolds for tissue engineering applications: 3D printing, electrospinning, rapid prototyping and self-assembly techniques such as Langmuir-Blodgett.
Lignin-derived scaffold for possible bone tissue engineering applications.
| Aim | Matrix Type | Additional Ingredients | Results | References |
|---|---|---|---|---|
| osteoconductivity | heat-treated birch wood | none | heat treatment of wood increases osteoconductivity | Rekola et al. 2009 [ |
| scaffold fabrication | alginate-lignin aerogel (lignin from wheat straw by enzymatic hydrolysis) | none | fluid uptake in Tris-HCl buffer of >1600%, good biocompatibility | Quraishi et al. 2015 [ |
| scaffold fabrication | starch, lignin (from Kraft lignin) or hemicellulose | none | hydrogels produced by reactive extrusion show pH dependent swelling behavior (water uptake at pH 9: from 400 to 1400%); the amount of citric acid used as cross-linker also influences both swelling and degradation of the hydrogels. Additional catalysts used during extrusion slow down degradation | Farhat et al. 2017 [ |
| scaffold fabrication | agarose-lignin composites (lignin from Kraft black liquor) | none | crosslinked agarose-lignin hydrogels exhibit enhanced mechanical properties compared to pure agarose gels | Techato et al. 2018 [ |
| influencing mechanical properties | lignin-chitosan microfibers | none | improving mechanical properties of chitosan fibers by adding 3% lignin | Wang et al. 2016 [ |
| influencing mechanical properties | poly(lactic acid) with lignin as filler (Kraft lignin) | none | lignin as filler does not decrease storage modulus, but inhibits PLA crystallization | Anwer et al. 2015 [ |
| influencing mechanical properties | poly(lactic acid) with up to 15% lignin as filler (Organosolv lignin from birch wood and Kraft lignin from softwood) | none | higher lignin content leads to higher tensile strength, but also slightly decreased water sorption capacity. Organosolv lignin yields slightly better mechanical results; good biocompatibility against SaOS-2 cells regardless of lignin type | Tanase et al. 2018 [ |
| influencing mechanical properties | lignin-based copolymer/polyester blend nanofibers (alkali lignin) | none | mechanical improvement dependent on polyester, good antioxidant activity and biocompatibility against NIH/3T3 fibroblasts | Kai et al. 2017 [ |
| bioactive coating for implants | hydroxyapatite/lignin composite coatings on titanium (Organosolv lignin) | doping of silver for antimicrobial effect | HA coatings on Ti were non-cytotoxic to peripheral blood mononuclear cells; Ag-doped coatings showed antibacterial behavior against | Erakovic et al. 2014 [ |
Figure 11Key molecules regulating adipogenesis and osteogenesis in mesenchymal stem cells. Runx2, Wnt10b, RhoA, and soft geometry can induce osteogenesis while inhibiting adipogenesis [108]. Copyright 2018 under the Creative Commons Attribute License.